{Reference Type}: Journal Article
{Title}: Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer.
{Author}: Jia D;Wang Q;Qi Y;Jiang Y;He J;Lin Y;Sun Y;Xu J;Chen W;Fan L;Yan R;Zhang W;Ren G;Xu C;Ge Q;Wang L;Liu W;Xu F;Wu P;Wang Y;Chen S;Wang L;
{Journal}: Cell
{Volume}: 187
{Issue}: 7
{Year}: 2024 Mar 28
{Factor}: 66.85
{DOI}: 10.1016/j.cell.2024.02.022
{Abstract}: The immune checkpoint blockade (ICB) response in human cancers is closely linked to the gut microbiota. Here, we report that the abundance of commensal Lactobacillus johnsonii is positively correlated with the responsiveness of ICB. Supplementation with Lactobacillus johnsonii or tryptophan-derived metabolite indole-3-propionic acid (IPA) enhances the efficacy of CD8+ T cell-mediated αPD-1 immunotherapy. Mechanistically, Lactobacillus johnsonii collaborates with Clostridium sporogenes to produce IPA. IPA modulates the stemness program of CD8+ T cells and facilitates the generation of progenitor exhausted CD8+ T cells (Tpex) by increasing H3K27 acetylation at the super-enhancer region of Tcf7. IPA improves ICB responsiveness at the pan-cancer level, including melanoma, breast cancer, and colorectal cancer. Collectively, our findings identify a microbial metabolite-immune regulatory pathway and suggest a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy.